Predicting the protein targets for athletic performance-enhancing substances

Journal of Cheminformatics

Volumn 5, Issue 6, 2013, Pages

  Mavridis, Lazaros ^a   Mitchell, John B O ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Drug repurposing; Drugs in sport; Machine learning; Multi label prediction; Polypharmacology; Protein target prediction; Side effects

Indexed keywords

EID: 84880054720     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/1758-2946-5-31     Document Type: Article

References (41)

1. World Anti-Doping Agency: 2012 Prohibited List. Montreal, Quebec: World Anti-Doping Agency; 2012.
2. Cannon EO, Bender A, Palmer DS, Mitchell J B O: Chemoinformatics-Based Classification of Prohibited Substances Employed for Doping in Sport. J Chem Inf Model 2006, 46:2369-2380. (Pubitemid 46008111)
3. Cannon EO, Mitchell J B O: Classifying the World Anti-Doping Agency's 2005 Prohibited List Using the Chemistry Development Kit Fingerprint. Lecture Notes in Bioinformatics 2006, 4216:173-182. (Pubitemid 44617787)
4. Cannon EO, Nigsch F, Mitchell J B O: Novel Hybrid Ultrafast Shape Descriptor Method for use in Virtual Screening. Chemistry Central Journal 2008, 2:3.
5. Bender A, Scheiber J, Glick M, Davies JW, Azzaoui K, Hamon J, Urban L, Whitebread S, Jenkins JL: Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. Chem Med Chem 2007, 2:861-873.
6. Nigsch F, Mitchell J B O: Toxicological Relationships Between Proteins Obtained from Protein Target Predictions of Large Toxicity Databases. Toxicol Appl Pharmacol 2008, 2313:225-234.
7. Nigsch F, Bender A, Jenkins JL, Mitchell J B O: Ligand-Target Prediction using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics. J Chem Inf Model 2008, 48:2313-2325.
8. Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, Jenkins JL, Lavan P, Weber E, Doak AK, Cote S, Shoichet BK, Urban L: Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012, 486:361-367.
9. Perez-Nueno VI, Venkatraman V, Mavridis L, Ritchie DW: Detecting Drug Promiscuity Using Gaussian Ensemble Screening. J Chem Inf Model 2012, 52:1948-1961.
10. Niijima S, Yabuuchi H, Okuno Y: Cross-Target View to Feature Selection: Identification of Molecular Interaction Features in Ligand-Target Space. J Chem Inf Model 2011, 51:15-24.
11. Paolini VG, Shapland R H B, Van Hoorn WP, Mason JS, Hopkins AL: Global mapping of pharmacological space. Nat Biotechnol 2006, 24:805-815. (Pubitemid 44086621)
12. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas K L H, Edwards DD, Shoichet BK, Roth BL: Predicting new molecular targets for known drugs. Nature 2009, 462:175-181.
13. Lowe R, Mussa HY, Nigsch F, Glen RC, Mitchell J B O: Predicting the mechanism of phospholipidosis. J Cheminformatics 2012, 4:2.
14. Gaulton A, Bellis LJ, Bento PA, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP: ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 2012, 40:D1100-D1107.
15. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 2007, 35:D198-D201. (Pubitemid 46056198)
16. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Whishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39:D1035-D1041.
17. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Zhou Z, Han L, Karapetyan K, Dracheva S, Shoemaker BA, Bolton E, Gindulyte A, Bryant SH: PubChem's BioAssay Database. Nucleic Acids Res 2012, 40:D400-D412.
18. Zhang J, Aizawa M, Amari S, Iwasawa Y, Nakano T, Nakata K: Development of KiBank, a database supporting structure-based drug design. Comput Biol Chem 2004, 28:401-407.
19. Roth BL, Lopez E, Patel S, Kroeze WK: The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches. Neuroscientist 2000, 6:252-262. (Pubitemid 30619585)
20. Kim Kjaerulff S, Wich L, Kringelum J, Jacobsen UP, Kouskoumvekaki I, Audouze K, Lund O, Brunak S, Oprea TI, Taboureau O: ChemProt-2.0: visual navigation in a disease chemical biology database. Nucleic Acids Res 2013, 41:D464-D469.
21. Wang R, Fang X, Lu Y, Yang CY, Wang S: The PDBbind Database: Methodologies and Updates. J Med Chem 2005, 48:4111-4119. (Pubitemid 40800619)
22. Olah M, Mracec M, Ostopovici L, Rad R, Bora A, Hadaruga N, Olah I, Banda M, Simon Z, Mracec M, Oprea TI: WOMBAT: World of Molecular Bioactivity. New York: Wiley-VCH; 2004:223-239.
23. Accerlys: MDL Drug Data Report; 2010. http://www.akosgmbh.de/Symyx/ software/databases/mddr.htm (accessed Jan 15, 2012).
24. Mavridis L, Nath N, Mitchell J B O: PFClust: A Novel Parameter Free Clustering Algorithm. BMC Bioinformatics 2013, 14. Accepted.
25. Glen RC, Bender A, Arnby CH, Carlsson L, Boyer S, Smith J: Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. IDrugs 2006, 9:199-204.
26. Rogers DJ, Tanimoto TT: A Computer Program for Classifying Plants. Science 1960, 132:1115-1118.
27. Parzen E: On Estimation of a Probability Density Function and Mode. Ann. Math. Statist. 1962, 33:1065-1076.
28. Rosenblatt M: Remarks on Some Nonparametric Estimates of a Density Function. Ann Math Statist 1956, 27:832-837.
29. Matthews BW: Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 1975, 405:442-451.
30. Arborelius L, Linner L, Wallsten C, Ahlenius S, Svensson TH: Partial 5-HT1A receptor agonist properties of (-) pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo. Psychopharmacology (Ber), 151:77-84. 200.
31. Jorge-Rivera JC, McIntyre KL, Henderson LP: Anabolic steroids induce region-and subunit-specific rapid modulation of GABA (A) receptormediated currents in the rat forebrain. J Neurophysiol 2000, 83:3299-3309. (Pubitemid 30408865)
32. Zhang Y, Yang L: Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol 2009, 5:621-629.
33. Rao GS, Haueter G, Rao ML, Breuer H: Steroid glucuronyltransferases of rat liver. Properties of oestrone and testosterone glucuronyltransferases and the effect of ovariectomy, castration and administration of steroids on the enzymes. Biochem J 1977, 162:545-556. (Pubitemid 8060790)
34. Supuran CT, Scozzafava A: Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000, 10:575-600. (Pubitemid 30251754)
35. Rios GR, Tephly TR: Inhibition and active sites of UDP- glucuronosyltransferases 2B7 and 1A1. Drug Metab Dispos 2002, 30:1364-1367. (Pubitemid 35397039)
36. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS, Kim S, Lee JS, Choe KW, Song YW: Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 1998, 16:9-13. (Pubitemid 28133475)
37. Pepin J, Milord F, Khonde AN, Niyonsenga T, Loko L, Mpia B, De Walls P: Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg 1995, 89:92-97.
38. Cordeiro AT, Thiemann OH, Michels PA: Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Bioorg Med Chem 2009, 17:2483-2489.
39. Lam HY: Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 1984, 118:27-32. (Pubitemid 14191943)
40. De Gregorio MW, Ford JM, Benz CC, Wiebe VJ: Toremifene: Pharmacologic and Pharmacokinetic Basis of Reversing Multidrug Resistance. J Clin Oncol 1989, 7:1359-1364. (Pubitemid 19220141)
41. Torres GE, Gainetdinov RR, Caron MG: Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003, 4:13-25. (Pubitemid 37271085)